Decullier Evelyne, Lhéritier Véronique, Chapuis François
Clinical Research Unit, DIM des Hospices Civils de Lyon, 162 avenue Lacassagne, 69424 Lyon cedex 03, France.
BMJ. 2005 Jul 2;331(7507):19. doi: 10.1136/bmj.38488.385995.8F. Epub 2005 Jun 20.
To describe the fate of protocols approved by the French research ethics committees, a national system created by the French 1988 Huriet-Sérusclat Act; to assess publication bias at a national level.
Retrospective cohort study.
Representative sample of 25/48 French research ethics committees in 1994. PROTOCOLS: 649 research protocols approved by committees, with follow-up information.
Protocols' initial characteristics (design, study size, investigator) abstracted from committees' archives; follow-up information (rates of initiation, completion, and publication) obtained from mailed questionnaire to principal investigators.
Completed questionnaires were available for 649/976 (69%) protocols. Of these, 581 (90%) studies were initiated, 501/581 (86%) were completed, and 190/501 (38%) were published. Studies with confirmatory results were more likely to be published as scientific papers than were studies with inconclusive results (adjusted odds ratio 4.59, 95% confidence interval 2.21 to 9.54). Moreover, studies with confirmatory results were published more quickly than studies with inconclusive results (hazard ratio 2.48, 1.36 to 4.55).
At a national level, too many research studies are not completed, and among those completed too many are not published. We suggest capitalising on research ethics committees to register and follow all authorised research on human participants on a systematic and prospective basis.
描述法国研究伦理委员会批准的研究方案的后续情况,该委员会是根据法国1988年《于里埃 - 塞吕克拉法案》设立的全国性系统;评估全国范围内的发表偏倚。
回顾性队列研究。
1994年法国48个研究伦理委员会中的25个的代表性样本。
委员会批准的649项研究方案,并具备随访信息。
从委员会档案中提取的研究方案初始特征(设计、研究规模、研究者);通过向主要研究者邮寄问卷获得的随访信息(启动率、完成率和发表率)。
976项研究方案中有649项(69%)获得了完整的问卷回复。其中,581项(90%)研究启动,501/581项(86%)完成,190/501项(38%)发表。与结果无定论的研究相比,结果得到证实的研究更有可能作为科学论文发表(调整后的优势比为4.59,95%置信区间为2.21至9.54)。此外,结果得到证实的研究比结果无定论的研究发表得更快(风险比为2.48,1.36至4.55)。
在全国范围内,有太多的研究未完成,而那些完成的研究中又有太多未发表。我们建议利用研究伦理委员会,对所有经授权的人体研究参与者进行系统和前瞻性的登记及随访。